Identifying Effective Durations of Antibiotic Therapy for the Treatment of Carbapenem-resistant Enterobacterales Bloodstream Infections: A Multicenter Observational Study

被引：5
|
作者：
Soto, Caitlin L. [1 ]
Hsu, Alice J. [1 ]
Lee, Jae Hyoung [2 ]
Dzintars, Kathryn [1 ]
Choudhury, Rebecca [3 ]
Jenkins, Timothy C. [4 ]
Mccreary, Erin K. [5 ]
Quartuccio, Katelyn S. [6 ]
Stohs, Erica J. [7 ]
Zimmerman, Matty [1 ]
Tamma, Pranita D. [2 ,8 ]
机构：
[1] Johns Hopkins Univ Hosp, Dept Pharm, Baltimore, MD USA
[2] Johns Hopkins Univ, Dept Pediat, Baltimore, MD 21287 USA
[3] Montefiore Med Ctr, Dept Med, Bronx, NY USA
[4] Denver Hlth, Dept Med, Denver, CO USA
[5] Univ Pittsburgh, Dept Med, Sch Med, Pittsburgh, PA USA
[6] Univ Rochester, Med Ctr, Dept Pharm, Rochester, NY 14627 USA
[7] Univ Nebraska, Dept Med, Med Ctr, Omaha, NE USA
[8] Johns Hopkins Univ, Dept Pediat, Sch Med, 200 North Wolfe St,Rubinstein Bldg,Rm 3149, Baltimore, MD 21287 USA
来源：
CLINICAL INFECTIOUS DISEASES | 2024年 / 78卷 / 01期
关键词：
carbapenem-resistant Enterobacterales; bacteremia; ceftazidime-avibactam; meropenem-vaborbactam;
D O I：
10.1093/cid/ciad476
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
In a propensity-score-weighted cohort of 183 adults with carbapenem-resistant Enterobacterales bacteremia at 24 US hospitals, patients receiving short courses of active therapy (7-10 days, median 9 days) experienced similar odds of recurrent bacteremia or death within 30 days as those receiving prolonged courses of active therapy (14-21 days, median 14 days).
引用
收藏
页码：27 / 30
页数：4
相关论文
共 50 条
  • [31] An analysis of differences in Carbapenem-resistant Enterobacterales in different regions: a multicenter cross-sectional study
    Guo, Bo
    Li, Peili
    Qin, Bingyu
    Wang, Shanmei
    Zhang, Wenxiao
    Shi, Yuan
    Yang, Jianxu
    Niu, Jingjing
    Chen, Shifeng
    Chen, Xiao
    Cui, Lin
    Fu, Qizhi
    Guo, Lin
    Hou, Zhe
    Li, Hua
    Li, Xiaohui
    Liu, Ruifang
    Liu, Xiaojun
    Mao, Zhengrong
    Niu, Xingguo
    Qin, Chao
    Song, Xianrong
    Sun, Rongqing
    Sun, Tongwen
    Wang, Daoxie
    Wang, Yong
    Xu, Lanjuan
    Xu, Xin
    Yang, Yuejie
    Zhang, Baoquan
    Zhou, Dongmin
    Li, Zhaozhen
    Chen, Yinyin
    Jin, Yue
    Du, Juan
    Shao, Huanzhang
    BMC INFECTIOUS DISEASES, 2024, 24 (01)
  • [32] An analysis of differences in Carbapenem-resistant Enterobacterales in different regions: a multicenter cross-sectional study
    Bo Guo
    Peili Li
    Bingyu Qin
    Shanmei Wang
    Wenxiao Zhang
    Yuan Shi
    Jianxu Yang
    Jingjing Niu
    Shifeng Chen
    Xiao Chen
    Lin Cui
    Qizhi Fu
    Lin Guo
    Zhe Hou
    Hua Li
    Xiaohui Li
    Ruifang Liu
    Xiaojun Liu
    Zhengrong Mao
    Xingguo Niu
    Chao Qin
    Xianrong Song
    Rongqing Sun
    Tongwen Sun
    Daoxie Wang
    Yong Wang
    Lanjuan Xu
    Xin Xu
    Yuejie Yang
    Baoquan Zhang
    Dongmin Zhou
    Zhaozhen Li
    Yinyin Chen
    Yue Jin
    Juan Du
    Huanzhang Shao
    BMC Infectious Diseases, 24
  • [33] Clinical and economic outcomes attributable to carbapenem-resistant Enterobacterales and delayed appropriate antibiotic therapy in hospitalized patients
    Kengkla, Kirati
    Wongsalap, Yuttana
    Chaomuang, Natthaya
    Suthipinijtham, Pichaya
    Oberdorfer, Peninnah
    Saokaew, Surasak
    INFECTION CONTROL & HOSPITAL EPIDEMIOLOGY, 2022, 43 (10) : 1349 - 1359
  • [34] Bloodstream Infections in Patients with Rectal Colonization by Carbapenem-Resistant Enterobacteriaceae: A Prospective Cohort Study
    Chu, Wenwen
    Hang, Xiubing
    Li, Xin
    Ye, Naifang
    Tang, Wei
    Zhang, Yafei
    Yang, Xiyao
    Yang, Min
    Wang, Yansheng
    Liu, Zhou
    Zhou, Qiang
    INFECTION AND DRUG RESISTANCE, 2022, 15 : 6051 - 6063
  • [35] Hospital-Acquired Infections Caused by Carbapenem-Resistant Enterobacteriaceae: An Observational Study
    Aldali, Hamzah J. J.
    Khan, Azra
    Alshehri, Abdullah A. A.
    Aldali, Jehad A. A.
    Meo, Sultan Ayoub
    Hindi, Ali
    Elsokkary, Emadeldin M. M.
    MICROORGANISMS, 2023, 11 (06)
  • [36] Antibiotic Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae: Systematic Evaluation of the Available Evidence
    Falagas, Matthew E.
    Lourida, Panagiota
    Poulikakos, Panagiotis
    Rafailidis, Petros I.
    Tansarli, Giannoula S.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (02) : 654 - 663
  • [37] Ceftazidime-Avibactam as Salvage Therapy in Pediatric Liver Transplantation Patients with Infections Caused by Carbapenem-Resistant Enterobacterales
    Wang, Weili
    Wang, Rongrong
    Zhang, Yuntao
    Zeng, Lei
    Kong, Haisen
    Bai, Xueli
    Zhang, Wei
    Liang, Tingbo
    INFECTION AND DRUG RESISTANCE, 2022, 15 : 3323 - 3332
  • [38] High-dose tigecycline for the treatment of nosocomial carbapenem-resistant Klebsiella pneumoniae bloodstream infections A retrospective cohort study
    Geng, Ting-Ting
    Xu, Xin
    Huang, Man
    MEDICINE, 2018, 97 (08)
  • [39] Systematic Analysis of Mobile Genetic Elements Mediating β-Lactamase Gene Amplification in Noncarbapenemase-Producing Carbapenem-Resistant Enterobacterales Bloodstream Infections
    Shropshire, W. C.
    Konovalova, A.
    McDaneld, P.
    Gohel, M.
    Strope, B.
    Sahasrabhojane, P.
    Tran, C. N.
    Greenberg, D.
    Kim, J.
    Zhan, X.
    Aitken, S.
    Bhatti, M.
    Savidge, T. C.
    Treangen, T. J.
    Hanson, B. M.
    Arias, C. A.
    Shelburne, S. A.
    MSYSTEMS, 2022, 7 (05)
  • [40] Multicenter Study of Outcomes with Ceftazidime-Avibactam in Patients with Carbapenem-Resistant Enterobacteriaceae Infections
    King, Madeline
    Heil, Emily
    Kuriakose, Safia
    Bias, Tiffany
    Huang, Vanthida
    El-Beyrouty, Claudine
    McCoy, Dorothy
    Hiles, Jon
    Richards, Lynette
    Gardner, Julianne
    Harrington, Nicole
    Biason, Kenneth
    Gallagher, Jason C.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (07)
12345